What are thiazide diuretics, really?
Thiazide diuretics are, in plain terms, "water pills" for blood pressure. They nudge your kidneys into passing a little more salt and water than they otherwise would, and over weeks that gentle nudge settles your blood pressure a few notches lower. The family includes hydrochlorothiazide — HCTZ, sold as Microzide, and by far the most prescribed member worldwide — along with chlorthalidone, indapamide (Natrilix in the UK), metolazone, and bendroflumethiazide, which is the standard first-line choice across much of Britain. Some of these are true thiazides and some are "thiazide-like" (more on that distinction later), but they all aim at the same tiny target and behave, clinically, as one group.
They belong to the broader world of diuretics — if you want the wide-angle view of every kind of water pill, start with our overview of diuretics, and if you want their heavier-hitting cousins, the loop diuretics get their own article. The one idea worth carrying into everything below: thiazides are a management tool, not a cure. They control a number. They do not repair the plumbing that let the number climb in the first place.
How they work — the simple version
Picture your kidney as a salt-recycling plant. Blood gets filtered at the top, and an enormous amount of sodium spills into a long, winding pipe called the nephron. Letting all of that salt leave in your urine would be a catastrophe, so the plant has a series of recovery stations along the pipe, each one grabbing sodium back and returning it to your blood. Where salt goes, water follows — that is just osmosis doing its job — so recovering salt also recovers water, and holding onto both keeps your blood volume, and your blood pressure, up.
The busiest recovery station is a stretch called the Loop of Henle. That is the loading dock the loop diuretics shut down, which is why they are so powerful. Thiazides work further downstream, at a quieter station called the distal convoluted tubule, and they jam exactly one piece of machinery there: the sodium-chloride cotransporter (its gene name is SLC12A3, if you ever see it on a lab report). That transporter is a doorway that hauls sodium and chloride back into the blood together. Thiazides padlock the doorway.
Here is the useful metaphor. If loop diuretics chain the main loading dock shut, thiazides padlock a secondary side entrance. The side entrance handles far less traffic — which is exactly why thiazides are milder than loops and a poor choice when you need to move a lot of fluid fast. But padlock that side door every single day, month after month, and you still shift a meaningful amount of salt out of the body. For chronic high blood pressure, "meaningful amount, every day, for years, cheaply, in one small pill" turns out to be precisely what you want.
What else they do to your body, beyond lowering blood pressure
Once you see the padlocked doorway, the side effects stop looking like a scary random list and start looking like consequences. You blocked salt reabsorption at one station. Everything downstream of that station now has to deal with salt that was supposed to be gone — and your blood chemistry gets rearranged in five fairly predictable ways.
Potassium goes down (hypokalemia). The sodium that thiazides refuse to reabsorb keeps flowing down the pipe to the final station, the collecting duct. A hormone called aldosterone runs that station, and it reads all that arriving sodium as a signal: "trade it — pull this sodium back, and flush potassium out to balance the books." So potassium spills into your urine. This is why anyone on a thiazide gets their potassium checked, and why the low is worth taking seriously. It is also the single most elegant reason for one of medicine's favorite pairings, which we will get to below.
Sodium can go down too (hyponatremia). Thiazides quietly sabotage the kidney's ability to make dilute urine — its ability to dump plain water without dumping salt. Most of the time that is harmless. But in someone whose body is already clinging to water (older adults, people who are ill or stressed, an underactive thyroid), the kidney can no longer flush off the excess, and the sodium in the blood gets diluted down. Worth knowing: thiazides cause this more often than loop diuretics do, and in elderly patients it can become severe and sneak up with almost no warning.
Calcium goes up (and urinary calcium goes down). Blocking that sodium doorway lowers the sodium level inside the tubule cell. To compensate, a sodium-calcium exchanger on the cell works harder, and in doing so it pulls extra calcium out of the urine and back into the blood. The result is slightly higher blood calcium and much less calcium in the urine. Tom Nijenhuis and colleagues mapped this mechanism out in careful detail in the Journal of Clinical Investigation in 2005. Loop diuretics do the opposite and waste calcium — which, as we will see, gives thiazides a surprising second career.
Uric acid goes up (gout risk). Deep in the kidney, thiazides and uric acid compete for the same shuttle — an organic anion transporter — to get where they are going. With thiazide molecules hogging the shuttle, more uric acid gets reabsorbed instead of excreted, and blood uric acid creeps up. For someone prone to gout, that creep can tip into a flare.
Blood sugar and blood fats can drift up. When potassium runs low, the pancreas releases insulin a little less efficiently, so blood sugar can rise — an effect that mattered more in the era of big doses and matters much less with today's low-dose regimens. There is also a small, dose-dependent bump in triglycerides and LDL cholesterol, again mostly a historical concern from the high-dose years. Ernst and Moser laid out how much of this is simply a function of dose.
None of this makes thiazides bad drugs. It makes them double-edged, in the honest way most useful drugs are. The chemistry they shift to lower your pressure is the same chemistry that occasionally needs watching.
What people usually take with them, and why
The most important thing to understand about thiazides is that they are rarely a solo act, and the reasons are guideline-backed rather than folklore.
The classic hypertension pairing. Both the 2017 ACC/AHA guideline (Whelton and colleagues) and the 2018 ESC/ESH guideline (Williams and colleagues) put thiazide-type diuretics on the short list of first-line blood pressure drugs. Their favorite dance partner is a drug that blocks the renin-angiotensin system — either an ACE inhibitor or an angiotensin receptor blocker (ARB). The logic is beautiful. Remember that aldosterone flushing your potassium? ACE inhibitors and ARBs turn aldosterone down. So the partner drug blunts exactly the potassium loss the thiazide causes, while the two together lower blood pressure more than either could alone. That is why fixed-dose combinations like losartan-plus-HCTZ are among the most prescribed pills on the planet: two mechanisms, one tablet, and each one covering the other's weakness.
Chlorthalidone, and why the trial evidence favors it. The landmark ALLHAT trial, published in JAMA in 2002, randomized tens of thousands of high-risk hypertensive patients and found that a diuretic-based regimen held its own against both an ACE inhibitor and a calcium channel blocker for cardiovascular outcomes — and actually beat the ACE inhibitor at preventing heart failure. The crucial footnote most people skip: ALLHAT used chlorthalidone, not HCTZ. A later cohort analysis by Dorsch and colleagues found chlorthalidone reduced cardiovascular events more than HCTZ did. This is why the 2017 ACC/AHA guideline nudges toward chlorthalidone when a thiazide is chosen.
Kidney stones — the plot twist. Remember that thiazides pull calcium out of the urine? Less calcium in the urine means less raw material for calcium oxalate kidney stones. So thiazides are used, off the beaten path, to help prevent recurrent calcium stones — a genuinely surprising job for a "blood pressure pill."
Nephrogenic diabetes insipidus — the paradox. Here is the mechanism doing something that sounds impossible. In nephrogenic diabetes insipidus, the kidney can't concentrate urine and floods the body with dilute urine. Give a thiazide — a water pill — and urine volume goes down. The trick: the mild volume depletion the thiazide creates makes the upstream part of the nephron reabsorb more sodium and water on its own, so less fluid ever reaches the broken downstream station. The kidney ends up thirsty, and the "water pill" quietly becomes a water-saver.
Heart failure — a supporting role only. In acutely decompensated heart failure, thiazides are not the answer; that is loop-diuretic territory, and it belongs in the loop diuretics article. But in stubborn, refractory fluid overload, adding a thiazide (often metolazone) on top of a loop diuretic hits two different nephron stations at once and produces an outsized, synergistic flush. It is a specialist maneuver, not a starting move.
Red flags — when to call a doctor
Thiazides are gentle drugs that occasionally do ungentle things to your blood chemistry, and the warning signs are worth knowing — not to self-diagnose, but to know when a phone call to your clinician is not optional.
- Muscle cramps, unusual weakness, or a fluttering, pounding heartbeat. These can point to low potassium (or low magnesium), and the heart-rhythm angle is why they get taken seriously.
- New confusion, drowsiness, or nausea in an older person on a thiazide. This is the classic quiet face of low sodium, and it can build up over days with almost no drama until it is severe.
- Sudden, savage joint pain — the big toe is the stereotype. That is what a gout flare from rising uric acid feels like.
- Dizziness or lightheadedness when you stand up, especially in the first weeks. Blood pressure that drops too far on standing is common early and worth reporting.
- A diabetic seeing their blood sugar climb, along with new thirst, deserves a conversation rather than a shrug.
None of these mean panic. All of them mean this is a "check in with a professional" situation, not a "wait and see for a week" one.
What people get wrong
"All diuretics drain your potassium." Not true across the board. A whole class — the potassium-sparing diuretics, like spironolactone, eplerenone and amiloride — does the opposite and can push potassium up. Thiazides and loops lower it; the sparers raise it. Lumping them together gets the chemistry backwards.
"HCTZ and chlorthalidone are basically the same pill." They are not. Chlorthalidone's effect lasts roughly three times as long — its half-life is around two days versus HCTZ's several hours — and it carries the stronger cardiovascular outcome evidence, which is exactly why ALLHAT used it and why guidelines lean toward it. Same target, meaningfully different drug.
"Indapamide isn't even a real thiazide." Technically correct, practically irrelevant. Indapamide and chlorthalidone are "thiazide-like": they lack the classic benzothiadiazine chemical ring, so a chemist would object to the label. But they block the same sodium-chloride transporter and behave the same way at the bedside, side effects and all. The group behaves as one.
"Thiazides are banned in sport, and that's a myth." It is not a myth — it is true. Thiazide diuretics sit on the WADA Prohibited List, not because they build anyone up, but because they can be used as masking agents to dilute urine and hide traces of other banned drugs. Athletes on a legitimate prescription need the paperwork.
"You should drink less water while you're on a water pill." Backwards, and occasionally dangerous. Deliberate dehydration makes every electrolyte problem above worse, not better. Normal, sensible hydration is exactly what you want — the drug handles the fluid math, not your thirst.
"Thiazides are only for blood pressure." As we have seen, they also prevent certain kidney stones, paradoxically treat nephrogenic diabetes insipidus, and — through that same calcium-retaining trick — may modestly support bone density. A remarkably versatile little pill for something that started life as a blood pressure tablet.